Literature DB >> 2427575

Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody.

P L Stern, N Beresford, S Thompson, P M Johnson, P D Webb, N Hole.   

Abstract

The murine monoclonal antibody H316 recognizes cell surface glycoproteins shared in expression by human trophoblast and peripheral blood leukocytes. It is also strongly expressed by many human tumor cell types, including choriocarcinoma and teratocarcinoma. The H316 antigenic determinant from these different cell types is carried on two wheat germ agglutinin-reactive glycoproteins of approximately 65,000 and 55,000 m.w. The antigenicity is not dependent on N-linked glycosylation. Biochemical fractionation procedures suggest that the molecules are related to each other, are not associated through intermolecular disulfide bonds, but do exhibit intramolecular disulfide interactions. These glycoproteins demonstrate m.w. heterogeneity between different cell lines and individual trophoblast membrane preparations. Such properties suggest that H316 molecules may be representative of TLX antigens (trophoblast-leukocyte common antigens), which have been suggested to influence maternofetal immunogenetic interactions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427575

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement.

Authors:  M Matsumoto; T Seya; S Nagasawa
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

Review 2.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

3.  Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen.

Authors:  David M Shaw; Andrew M Woods; Kevin A Myers; Caroline Westwater; Veena Rahi-Saund; Michael J Davies; David V Renouf; Elizabeth F Hounsell; Peter L Stern
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

Review 4.  [Immunologically-induced abortion--diagnosis and therapy].

Authors:  M von Ditfurth; B M Kuntz; U Kuhn; W Distler
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

5.  Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation.

Authors:  D F Purcell; S M Russell; N J Deacon; M A Brown; D J Hooker; I F McKenzie
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

6.  Identification and quantification of complement regulator CD46 on normal human tissues.

Authors:  R W Johnstone; B E Loveland; I F McKenzie
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

Review 7.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

8.  Expression of the CD46 antigen, and absence of class I MHC antigen, on the human oocyte and preimplantation blastocyst.

Authors:  J M Roberts; C T Taylor; G C Melling; C R Kingsland; P M Johnson
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

9.  Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.

Authors:  Y Murakami; T Seya; M Kurita; A Fukui; S Ueda; S Nagasawa
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

10.  Soluble forms of membrane cofactor protein (CD46, MCP) are present in plasma, tears, and seminal fluid in normal subjects.

Authors:  T Hara; S Kuriyama; H Kiyohara; Y Nagase; M Matsumoto; T Seya
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.